Signal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases (Q56813382)

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Recent advances in the genetics of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Human morbid genetics revisited: relevance of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Does the genotype for schizophrenia often remain unexpressed because of canalization and stochastic events during development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Prefrontal neurons and the genetics of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Preclinical models: status of basic research in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Molecular targets of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Effects of the anticonvulsant sodium valproate on gamma-aminobutyrate and aldehyde metabolism in ox brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Mechanisms of action of valproate: a commentatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Mood stabilizer psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

New directions in the development of antidepressants: the interface of neurobiology and psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Initiation and adaptation: a paradigm for understanding psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Signaling networks in the pathophysiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The genes and brains of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Schizophrenia: reproductive hormones and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

PAK3 mutation in nonsyndromic X-linked mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Alternative splicing in the nervous system: an emerging source of diversity and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Calcineurin as a multifunctional regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Cain, a novel physiologic protein inhibitor of calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

High brain densities of the immunophilin FKBP colocalized with calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Association of protein kinase A and protein phosphatase 2B with a common anchoring protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Schizophrenia as a disorder of neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Neurochemical brain imaging investigations of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Ionotropic glutamate receptors as therapeutic targets in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

CREB phosphorylation and dephosphorylation: a Ca(2 )- and stimulus duration-dependent switch for hippocampal gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Ca2 -induced apoptosis through calcineurin dephosphorylation of BAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Inducible and reversible gene expression with the rtTA system for the study of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Linkage analysis in psychiatric disorders: the emerging picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Wnt signaling function in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Synaptic desensitization of NMDA receptors by calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49

Mood disorders and medical illness: a major public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.207.PE49